Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Gefurulimab for Children and Teens with Generalized Myasthenia Gravis

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study on the Safety and Effects of YTB323 and Drug Combination for Patients with Treatment-Resistant Generalized Myasthenia Gravis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    France
  • Study on Efgartigimod for Early Treatment in Patients with Generalized Myasthenia Gravis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study of Efgartigimod PH20 SC for Children Aged 2 to 17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1 1
    Investigated Drugs:
    Belgium Czechia France Germany Italy The Netherlands +2
  • Study on the Long-term Safety of Efgartigimod for Children with Generalized Myasthenia Gravis

    Recruiting

    4 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Italy +3
  • Study on Corticosteroids and Rituximab to Prevent Worsening of Ocular Myasthenia Gravis in Newly Diagnosed Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study of KYV-101 Therapy for Patients with Refractory Generalized Myasthenia Gravis

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Germany
  • Study on the Safety and Effectiveness of NMD670 for Adults with Myasthenia Gravis

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark France Italy The Netherlands Poland +1
  • Study on Efgartigimod for Children Aged 2-17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Poland +1
  • Study on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark France Germany Greece Italy The Netherlands +3